Kairos Pharma (KAPA) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kairos Pharma is the larger company by market cap ($3.1 million vs $1.9 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | KAPA | SBFM |
|---|---|---|
| Share price | $0.9272 | $0.43 |
| Market cap | $3.14M | $1.85M |
| 1-day change | +6.57% | -38.57% |
| Forward P/E | — | 0.00 |
| EPS (TTM) | $-1.96 | $-9.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.59 | $24.30 |
| 52-week low | $0.848 | $0.356 |
| Distance from 52-week high | -90.33% | -98.23% |
| Average volume | 512.51K | 3.33M |
| Shares outstanding | 3.39M | 4.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
KAPA vs SBFM FAQ
Which is bigger, Kairos Pharma or Sunshine Biopharma?
Kairos Pharma (KAPA) is larger, with a market capitalization of $3.14M compared with $1.85M for Sunshine Biopharma (SBFM).
Are Kairos Pharma and Sunshine Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.